Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 110.00 | 100.00 | 1.1000 | 1.1079 | |
| BT-20 | Linsitinib | 19.9526 | uM | 8 | 156.25 | 28.44 | 63.00 | 100.00 | 0.6300 | 0.5503 |
| BT-20 | Linsitinib | 3.1623 | uM | 8 | 156.25 | 28.44 | 93.00 | 100.00 | 0.9300 | 0.9216 |
| BT-20 | Lapatinib | 0.0033113 | uM | 8 | 156.25 | 28.44 | 100.00 | 100.00 | 1.0000 | 1.0000 |
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 156.25 | 28.44 | 133.00 | 100.00 | 1.3300 | 1.3405 |
| BT-20 | Linsitinib | 0.1 | uM | 8 | 156.25 | 28.44 | 111.00 | 100.00 | 1.1100 | 1.1184 |
| BT-20 | Lapatinib | 0.1 | uM | 8 | 156.25 | 28.44 | 132.00 | 100.00 | 1.3200 | 1.3307 |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 149.00 | 100.00 | 1.4900 | 1.4917 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 8 | 156.25 | 28.44 | 127.00 | 100.00 | 1.2700 | 1.2817 |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 133.00 | 100.00 | 1.3300 | 1.3405 | |
| BT-20 | Linsitinib | 0.01 | uM | 8 | 156.25 | 28.44 | 94.00 | 100.00 | 0.9400 | 0.9329 |
| BT-20 | 17-AAG | 0.1 | uM | 8 | 156.25 | 28.44 | 54.00 | 100.00 | 0.5400 | 0.4240 |
| BT-20 | Lapatinib | 0.01 | uM | 8 | 156.25 | 28.44 | 108.00 | 100.00 | 1.0800 | 1.0867 |
| BT-20 | Lapatinib | 0.31623 | uM | 8 | 156.25 | 28.44 | 107.00 | 100.00 | 1.0700 | 1.0760 |
| BT-20 | 17-AAG | 0.31623 | uM | 8 | 156.25 | 28.44 | 30.00 | 100.00 | 0.3000 | 0.0299 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 156.25 | 28.44 | 130.00 | 100.00 | 1.3000 | 1.3112 |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 117.00 | 100.00 | 1.1700 | 1.1808 | |
| BT-20 | Erlotinib | 19.9526 | uM | 8 | 156.25 | 28.44 | 189.00 | 100.00 | 1.8900 | 1.8407 |
| BT-20 | Lapatinib | 0.031623 | uM | 8 | 156.25 | 28.44 | 110.00 | 100.00 | 1.1000 | 1.1079 |
| BT-20 | Lapatinib | 0.0016596 | uM | 8 | 156.25 | 28.44 | 110.00 | 100.00 | 1.1000 | 1.1079 |
| BT-20 | 17-AAG | 0.031623 | uM | 8 | 156.25 | 28.44 | 47.00 | 100.00 | 0.4700 | 0.3191 |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 66.00 | 100.00 | 0.6600 | 0.5906 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 104.00 | 100.00 | 1.0400 | 1.0437 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 232.00 | 249.25 | 0.9308 | 0.8543 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 217.00 | 249.25 | 0.8706 | 0.7281 |